Invivyd’s Insider Buy Signals Confidence in NVD200’s Phase III Future
Invivyd insider buy of 1.125M shares shows senior leadership confidence in Phase III NVD200, boosting investor outlook and market‑access prospects.
4 minutes to read
INVIVYD INC
Invivyd Insider Trades Reveal Confidence Ahead of Phase‑3 COVID Antibody Milestone
Invivyd insider buys and tax‑cover sells show leadership’s confidence, with Phase 3 data poised to shift a speculative stock toward real revenue.
5 minutes to read
Invivyd CFO & Execs Buy Shares, Signaling Confidence Despite Volatile Market
Invivyd’s CFO and C‑suite buy 2.8 M zero‑cost options, signaling confidence in a rising share price amid volatility and a hopeful 2026 outlook for its NVD200 antibody pipeline.
3 minutes to read